Effect of the Fluoroquinolone Antibacterial Agent DX-619 on the Apparent Formation and Renal Clearances of 6β-Hydroxycortisol, an Endogenous Probe for CYP3A4 Inhibition, in Healthy Subjects

[1]  Yuichi Sugiyama,et al.  Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2]  Katsuhisa Inoue,et al.  Functional Characterization of Multidrug and Toxin Extrusion Protein 1 as a Facilitative Transporter for Fluoroquinolones , 2009, Journal of Pharmacology and Experimental Therapeutics.

[3]  B. K. Park,et al.  Cortisol metabolism by human liver in vitro—I. Metabolite identification and inter-individual variability , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  Y. Kasuya,et al.  Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[5]  H. Kusuhara,et al.  Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone , 2010, Journal of Pharmacology and Experimental Therapeutics.

[6]  R Hori,et al.  Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.

[7]  A. Smith,et al.  Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum. , 1998, Journal of the National Cancer Institute.

[8]  Kenichi Sato,et al.  In Vitro Antibacterial Activity of DX-619, a Novel Des-Fluoro(6) Quinolone , 2005, Antimicrobial Agents and Chemotherapy.

[9]  N. Isoherranen,et al.  Evaluation of 6β‐Hydroxycortisol, 6β‐Hydroxycortisone, and a Combination of the Two as Endogenous Probes for Inhibition of CYP3A4 In Vivo , 2011, Clinical pharmacology and therapeutics.

[10]  Yuichi Sugiyama,et al.  Characterization of the Uptake of Organic Anion Transporter (OAT) 1 and OAT3 Substrates by Human Kidney Slices , 2007, Journal of Pharmacology and Experimental Therapeutics.

[11]  P. Saenger.  6 beta-hydroxycortisol in random urine samples as an indicator of enzyme induction. , 1983, Clinical pharmacology and therapeutics.

[12]  Hiroaki Yuasa,et al.  The Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by Cimetidine , 2009, Drug Metabolism and Disposition.

[13]  A. Goldsobel.  TERFENADINE-KETOCONAZOLE INTERACTION: PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CONSEQUENCES , 1994, Pediatrics.

[14]  J. Leonard,et al.  Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects , 1997, Antimicrobial agents and chemotherapy.

[15]  C. Edwards,et al.  Edinburgh Research Explorer Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2 , 2022 .

[16]  G. Burckhardt,et al.  Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells , 2005, Pflügers Archiv.

[17]  R. Cutler,et al.  Time‐course of interaction between carbamazepine and clonazepam in normal man , 1978, Clinical pharmacology and therapeutics.

[18]  A. Enomoto,et al.  Interactions of human organic anion as well as cation transporters with indoxyl sulfate. , 2003, European journal of pharmacology.

[19]  N. Okudaira,et al.  Risk Assessment for Drug-Drug Interaction Caused by Metabolism-Based Inhibition of CYP3A Using Automated in Vitro Assay Systems and Its Application in the Early Drug Discovery Process , 2007, Drug Metabolism and Disposition.

[20]  H. Echizen,et al.  Dose‐dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6β‐hydroxycortisol , 2002, Clinical pharmacology and therapeutics.

[21]  H. Kusuhara,et al.  Prediction of Fluoroquinolone‐Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion , 2011, Clinical pharmacology and therapeutics.

[22]  M. Fromm,et al.  Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin , 1996, Hepatology.

[23]  Hiroshi Omote,et al.  A human transporter protein that mediates the final excretion step for toxic organic cations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Y. Sugiyama,et al.  Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4 , 2000, Pharmaceutical Research.

[25]  T. Bienvenu,et al.  A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans. , 1991, International journal of clinical pharmacology, therapy, and toxicology.

[26]  P. Saenger.  6β‐Hydroxycortisol in random urine samples as an indicator of enzyme induction , 1983 .

[27]  C. Kim,et al.  Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors. , 2009, Analytical biochemistry.

[28]  Nigel J Waters,et al.  Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. , 2008, Journal of pharmaceutical sciences.

[29]  G. Kearns,et al.  Cytochrome P450 3A , 1999, Clinical pharmacokinetics.